Form D · Biotechnology
Creatics LLC
Braintree, MA · CIK 0001547279
Offering snapshot reported Apr 27, 2012 · SEC filing
- Reported sold
- $582K Offering amount: $600K
- Investors reported
- 22 Form D · investor count
- Minimum accepted
- $3K Reported outside-investor minimum
- First sale
- Apr 13, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 27, 2012 | Initial | $582,000 | No comparison | 22 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 04
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-177390
Source: Form D, filed Apr 27, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mark Cleveland | Director, Executive, Promoter |
| Harry P. Keegan Iii | Director, Executive, Promoter |
| Harry P. Keegan Iv | Director, Executive, Promoter |
| Thomas Kelly | Director, Executive, Promoter |
| Robert Raleigh | Director, Executive, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
60 Columbian Street West
Braintree, MA, 02185-0929
Braintree, MA, 02185-0929